Sign in

CIK 0000906709

  • Non-accelerated filer
  • Smaller reporting company

NEKTAR THERAPEUTICS

Sign in to watch
Ticker
NKTR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
943134940
Phone
+1 415-482-5300
Business address
455 MISSION BAY BOULEVARD SOUTH, SAN FRANCISCO, CA, 94158
Former names
INHALE THERAPEUTIC SYSTEMS INC, INHALE THERAPEUTIC SYSTEMS
  1. 4 Open-market sale Director sold 6,750 shares at $56.76 ($383,130)
  2. 4 Open-market sale Director sold 10,000 shares at $67.39 ($673,900)
  3. 4 Open-market sale Director sold 30,000 shares at an average $59.96 ($1,798,800)
  4. 4 Returned to the company SVP & Chief Accounting Officer returned 4,883 shares (to the company)
  5. 4 Returned to the company SVP & Chief Operating Officer returned 8,137 shares (to the company)
  6. 4 Returned to the company SVP & Chief Financial Officer returned 8,207 shares (to the company)
  7. 4 Returned to the company SVP Pharma Dev & Mfg Ops returned 5,946 shares (to the company)
  8. 4 Returned to the company President & CEO returned 60,389 shares (to the company)
  9. 4 Returned to the company SVP & Chief Scientific Officer returned 6,701 shares (to the company)
  10. 4 Open-market sale Director sold 34,250 shares at an average $60.60 ($2,075,379)
  11. 4 Open-market sale President & CEO sold 130,000 shares at an average $49.52 ($6,438,036)
  12. 4 Open-market buy Director bought 5,000 shares at an average $58.04 ($290,212)
  13. 4 Open-market sale Director sold 10,000 shares at $55.16 ($551,600)
  14. 4 Open-market sale Director sold 10,000 shares at an average $60.28 ($602,786)
  15. 4 Open-market sale SVP & Chief Accounting Officer sold 3,576 shares at $83.39 ($298,203)
  16. 4 Open-market sale President & CEO sold 12,791 shares at $83.39 ($1,066,641)
  17. 4 Open-market sale SVP & Chief Operating Officer sold 4,917 shares at $83.39 ($410,029)
  18. 4 Open-market sale SVP & Chief Financial Officer sold 4,941 shares at $83.39 ($412,030)
  19. 4 Open-market sale SVP Pharma Dev & Mfg Ops sold 4,060 shares at $83.39 ($338,563)
  20. 4 Open-market sale SVP & Chief Scientific Officer sold 3,435 shares at $83.39 ($286,445)

Page 17 of 49 · 970 filings